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1. Introduction 
Neurochemical studies clarify scientific mechanisms for neurochemicals in the nervous 
system. These include identification and characterization of neurotransmitters and 
neuromodulators supportive for neurotransmission in neuronal and glial cells networks in 
the brain. Neurochemicals based on neural mechanisms have been explained by the ongoing 
evolution of scientific techniques. These neurochemical techniques include 
immunohistochemistry, immunoblotting using species’ specific antibodies or radio-labeled 
substances, etc. And these techniques with electrophysiological methods will be powerful 
tools to describe the pathophysiological mechanisms of sepsis-related brain dysfunction.  
Neurochemical techniques are useful to examine the physiological mechanism of normal 
brain function such as synaptic transmission, plasticity and neurogenesis. On the other 
hand, these techniques are available to find pathogenesis of the brain. In this chapter, we’d 
like to focus on the brain pathophysiology, which is often confronted in an intensive care 
unit, ‘septic encephalopathy’. 
In normal condition, our brain is protected for its environment such as neurochemical 
balance by the barrier called ‘blood brain barrier (guardian of the brain)’. However, sepsis 
leads to be the impairment of blood brain barrier function (i.e., enhancement of permeability 
through blood brain barrier) and imbalance of neurotransmission. In addition, following 
sepsis, apoptotic signaling pathway is activated (Hotchkiss RS & Nicholson DW, 2006) and/ 
or chemical mediators passing through disrupted blood brain barrier lead to necrotic 
neuronal cell death accompanying with ischemia (Sharshar T et al, 2004) and edema (Kafa 
IM et al, 2007). These phenomena finally lead to the imbalance of brain activity after septic 
encephalopathy. 
 Next section, we introduce the neurochemical techniques in terms of the contents: 1) what 
are pathophysiological phenomena in sepsis and its related encephalopathy in combination 
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of inflammatory response, 2) how to examine the aberrant brain function, 3) what is the 
future for sepsis research. 
2. Sepsis 
2.1 Pathogenesis of sepsis 
2.1.1 Symptoms 
Sepsis is a systemic inflammatory state in the whole body by bacteria infection in the blood 
stream (i.e., systemic inflammatory response syndrome) (Bone RC et al, 1992). In systemic 
inflammatory response syndrome, the innate immune systems are overactivated. The 
systemic inflammatory response syndrome is characterized by the symptoms such as fever 
and hypotension in patients. In severe sepsis pathology, immunohistochemical studies 
using both of postmortem human and an animal model of sepsis in rodents reveal the brain 
ischemia (Sharshar T et al, 2004), edema (Pfister D et al, 2008), hemorrhage (Casanova E et 
al, 2001) after sepsis. On the other hand, following sepsis, several kinds of symptoms such as 
polyneuropathy are also observed. These symptoms enhance complexity of the septic 
pathophysiology (Bolton CF et al, 1993; Nauwynck M & Huyghens L, 1998). Hence, the 
septic conditions include neurological symptoms.  
2.1.2 Molecular mechanisms  
Molecular mechanism of immunology for sepsis is investigated. When pathogen (bacteria 
etc.) is invaded into the blood stream, it is recognized to be pathogen-associated molecular 
pattern such as lipopolysaccaride, bacterial component in immunological dendritic cells and 
T cells. When the pathogen-associated molecular pattern binds to toll-like receptor, the toll-
like receptor facilitates cytokine release (Kim KD et al, 2007). After the cytokine release, the 
septic condition triggers downstream signaling pathways. These pathways translocate and 
activate NF-kappa B in the nucleus through I-kappaB degradation and mitogen-activated 
protein kinase (MAPK) and JUN kinase activation. Finally, NF-kappaB drives transcription 
of interleukin family (interleukin -1, 2, 6, 8 and 12) and tumor necrosis factor-.  
2.1.3 Cytokine storm 
These activations lead to be cytokine storm (Harrison C, 2010). In fact, 30% of septic patients 
have serious symptoms without bacteremia in their blood (Sprung CL et al, 1990). The result 
suggests that after removal of bacteria, cytokine storm is a major factor for the tissue injury 
after severe sepsis. What is a player for accelerating cytokine storm?  Recent finding 
suggests that small protein ‘complement’ creates cytokine storm (Ward PA, 2010). The 
complement serves as a supportive factor to enhance the efficacy of antibodies in order to 
clear pathogen in the blood. The complement C5a has their receptors, C5aR and C5L2, in the 
pituitary and their receptors are up-regulated after sepsis. C5a is also performed as a central 
hub to activate various inflammatory responses including disseminated intravascular 
coagulation, systemic inflammatory response syndrome, lethal bacteremia, 
immunosuppression, septic shock and heart failure (Rittirsch D et al, 2008). Conversely, 
when the C5a is neutralized by specific antibody, blood brain barrier disruption and 
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pituitary dysfunction in severe sepsis is alleviated in the rat (Flierl MA et al, 2009). Hence, 
C5a will be a hopeful target for cytokine storm regulation after sepsis. 
2.1.4 Multiple organ dysfunction syndrome 
Because of the amplification of systemic inflammatory states after sepsis, without 
appropriate intensive care including antibiotic therapy, vasopressor medications, 
mechanical dialysis (Dellinger RP et al, 2008), systemic inflammatory response syndrome 
and cytokine storm then lead to be multiple organ dysfunction syndrome. Once sepsis is 
reached to multiple organ dysfunction syndrome, the patients are destined to be coma or 
delirium. Multiple organ dysfunction syndrome implicates in the pathogenesis of septic 
encephalopathy.      
2.2 Septic encephalopathy 
Septic encephalopathy is devastating syndrome results from systemic inflammatory 
response syndrome in sepsis. In patients after multiple organ dysfunction syndrome, septic 
encephalopathy is appeared. The symptoms of septic encephalopathy patients are 
characterized as long-term cognitive impairment including deficits in memory, attention, 
concentration of consciousness (Streck EL et al, 2008). Why do these symptoms occur? 
A lot of research groups have performed to tackle and continue the challenging to uncover 
the mystery of septic encephalopathy. Typical characteristic in septic encephalopathy is that 
the chemical substances in the whole body can access to the neuronal function in the brain 
after blood brain barrier (a guardian of brain) disruption. In fact, we find that occludin, the 
marker for tight junction, is drastically reduced in the mouse brain after septic 
encephalopathy (Imamura Y et al, 2011). This may cause the edema after septic 
encephalopathy (Papadopoulos MC et al, 1999). Then, what is the pathophysiology in the 
neurochemical substances related to septic encephalopathy? 
Several decade ago, several lines of research reports have been addressed for the possibility 
of neurotransmitters imbalance in septic encephalopathy. One of the possible suggestions to 
septic encephalopathy-induced abnormalities stems from amino acid derangements in 
septic patients (Freund HR et al, 1978). The altered patterns of plasma amino acids are well 
correlated between non- septic encephalopathy and severe septic encephalopathy groups 
(Freund H et al, 1979). For example, several amino acids including glutamate, aspartate and 
tryptophan are altered in septic encephalopathy patient. These amino acids serve as 
neurotransmitters or are utilized for synthesization of neurotransmitters. Furthermore, 
using an animal model of septic encephalopathy, it is also suggested that these amino acid 
alteration affect the neurotransmitter in the brain. After cecal ligation and puncture, an 
animal model of septic encephalopathy, in rat, neurotransmitters serotonin and 
norepinephrine are altered and the altered patterns are correlated with these differences of 
amino acids (Freund HR et al, 1986). Hence, monoamine neurotransmitters are aberrant in 
septic encephalopathy. In addition, as shown in the following section, glutamatergic 
neurotransmission may be also affected and synaptic plasticity is disturbed (Imamura Y et 
al, 2011). Altogether, a whole body inflammation after sepsis 1) leads to blood brain barrier 
disruption, 2) affects the neurotransmitter levels and 3) may lead to be the symptoms of 
septic encephalopathy.  
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3. Scientific techniques of neurochemistry: How to see synaptic mechanism 
in septic brain 
3.1 General mechanism of synaptic transmission in the brain 
Neurochemical studies have been performed to clarify the temporal and spatial distribution 
of substances (i.e., proteins, enzymes, etc.) in brain. In the brain, neuronal cells which are 
major components of nervous system including brain, spinal cord constitute synapses. 
When the neurons are electrically excitable, neurotransmitters are released from the 
terminal of neuronal synapses (i.e., pre-synaptic terminals). On the other hand, the other 
neurons which receive the neurotransmitters possess receptors (i.e., post-synaptic 
terminals). The receptors binding to neurotransmtters activate electrically post-synaptic 
neurons and thereby the neuronal information is processed in the brain (i.e., synaptic 
transmission). Furthermore, the synaptic transmission is modulated by various chemical 
mediators (i.e., carbon monooxide (CO), nitric oxide (NO) etc.). These mediators are also 
critical to induce synaptic plasticity (i.e., plastic changes of electrical strength or efficacy in 
synaptic transmission). Hence, the neurotransmitters such as glutamate, acethylcholine and 
monoamine are major neurochemical substances, furthermore, these chemical mediators are 
necessary for normal synaptic transmission and synaptic plasticity. Aberrant expressions of 
these neurochemicals impede on the synaptic functions.  
3.2 Sepsis affects synaptic receptor and its modulator 
After sepsis, synaptic transmission seems to be affected. Although, to date, no reports are 
found for the direct evidence for the aberrant synaptic transmission by sepsis, sepsis-
induced inflammatory cytokine alters the synaptic function. For example, interleukin-1ǃ, 
which is up-regulated after sepsis, inhibits the expression of excitatory neurotransmitter 
receptors such as N-methyl-d-aspartate (NMDA) receptor (Coogan A & O'Connor JJ, 1997) 
and ǂ-amino-3-hydoxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (Lai AY et al, 
2006). Conversely, interleukin -1ǃ enhances the expression level of inhibitory 
neurotransmitter receptor, gamma-aminobutyric acid (GABA) receptor (Serantes R et al, 
2006). In addition, NO synthase (NOS) were up-regulated after endotoxemia (El-Mas MM et 
al, 2011). These neurochemicals and their receptors are critical for synaptic transmission and 
plasticity. These findings suggest that the sepsis-induced downstream effects such as 
interleukin (i.e, cytokine) are possibly associated with imbalance of synaptic transmission 
and its plasticity.  
3.3 Neuochemical methods to uncover the effect of sepsis 
Our research group is challenging to tackle this issue (Imamura Y et al, 2011). To examine 
this, an animal model of sepsis is used. The methods are ‘cecal ligation and puncture’ and 
‘intraperitoneal injection of lipopolysaccharide (i.e., cell wall of gram negative bacteria)’. 
Compared to sham-operated animals (i.e., surgical operation without cecal ligation and 
puncture or intraperitoneally injected saline’, the difference is determined by biochemical 
assays. 
To visualize the dynamics of neurochemicals between the sham-operated mice and septic 
mice, our methods are 1) immunohistochemistry, 2) immunoblotting, 3) electrophysiology. 
These methods are well-established to examine the pathological condition by comparing 
with normal condition and its effect in animal models. For 1) immunohistochemistry, the 
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procedure is summarized in Figure 1A. In brief, immunohistochemical staining is usually 
performed in following steps: 1) septic brain is fixed in 1-4% paraformaldehyde solution in  
 
Fig. 1. Experimental procedure. A, immunohitochemistry. B, immunoblotting 
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phosphate buffered saline (PBS, pH = 7.2-7.4), 2) the brain is immersed in sucrose 
suspension for dehydration, embedded in optical cutting temperature compound and 
frozen in -80°C until use, 3) incubation with bovine serum albumin or serum solution to 
prevent non-specific binding of antibody which augments the background noise,  4) very 
thin brain slices (10 µm thick) are incubated with suspension including 1/100 -1/500 
concentration (it depends on the specificity of antibody) of primary antibodies, 4) secondary 
antibodies which illuminate specific wavelength (usually 300-700nm) to visualize the spatial 
distribution of the proteins. Statistical analyses are performed between sham-operated 
groups and septic groups under normalization of each signal intensity and area by the 
number of cells (using nuclei staining).  
Difference of amount of specific proteins after sepsis can be determined by immunoblotting 
(Figure 1B). Following suspension of tissue samples with homogenizer, the amount of total 
proteins in the brain mixture is measured by bradford protein assay for normalization 
between sample amounts. Then, the proteins are loaded with polyacrylamide gel 
electrophoresis. Amount of the subject protein samples transferred to PVDF membrane are 
determined by the specific primary antibody and the band intensities visualized by the 
enzyme, horse radish peroxidase, secondary antibody. 
Brain function was determined by electrophysiology. Field excitatory post-synaptic 
potentials (fEPSPs) recordings detect population neuronal activity from recording electrode 
placed in extracellular neurons. Since, the method is available when neurons are arranged 
coordinately, it is useful for study of long-potentiation (LTP). For LTP study, our research 
group uses following methods: 1) making brain slices including hippocampus (300 m 
thick) and maintaining them in perfusing solution (2-3 ml/min) of artificial cerebrospinal 
solution (ACSF) saturated with mixture gas of 95% oxygen and 5% carbon dioxide, 2) the 
hippocampal slices are transferred to the recording chamber and placed, 3) stimulation 
electrode is placed on perforant path fiber and recording is performed from neurons in 
dentate gyrus, 4) LTP is induced by the high frequency stimulation (100 Hz for 1sec x 
4times, interval 5min)(Figure 2).  
As a result, we find that endotoxemia after cecal ligation and puncture results in occludin 
(i.e., a marker for blood brain barrier) disruption (Figure 3), increased interleukin-1ǃ on 
microglial cells in the hippocampus of the brain (Figure 4) and up-regulated interleukin-1ǃ 
receptor on neurons (Figure 5).  
Importantly, LTP is unable to induce in a group of septic mice (Figure 6B). Several lines of 
studies indicate that interleukin-1ǃ inhibits LTP (Katsuki H et al, 1990; Ross FM et al, 2003). 
Due to these suggestions, we apply interleukin-1ǃ antagonist before LTP induction. 
Interleukin-1ǃ antagonist effectively cancels LTP deficiency after cecal ligation and puncture 
(Figure. 6C). These findings strongly suggest that increased interleukin in the brain after 
sepsis results in synaptic plasticity deficiency. Our approach successfully demonstrates the 
synaptic functional deficiency in septic encephalopathy and relevance of interleukin 
antagonist for the deficiency. However, there are still unclear for the following points: 1) 
effects of other inflammatory mediators, such as high mobility group box (HMGB)-1 (Zhao 
X et al, 2011) and tumor necrosis factor (Clark IA et al, 2010) which are expressed 
abundantly in the brain, to synaptic function, 2) How is the consequence of sepsis on the 
other brain regions except hippocampus. In following section, relevance of autonomic 
nervous system and a novel technology for the treatment and prescription of septic 
encephalopathy in the future are discussed.  
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Fig. 2. Long-term potentialtion (LTP) in the hippocampal slices. A, hippocampal slices from 
mouse brain. B, LTP is induced by high frequency stimulation (100Hz for 1sec x 4 times, 5 
min interval).  
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Fig. 3. Blood brain barrier disruption after cecal ligation and puncture. Occludin: a marker of 
blood brain barrier component. (A) Occludin immunoreactivity (a marker for blood brain 
barrier) in hippocampus from sham-operated mice (left panel) and cecal ligation and 
puncture (CLP) -treated mice (right panel). Magnified view shown in the lower right-hand 
corner. Red: occludin, blue: DAPI. (B) Lower intensity of occludin immunoreactivity in mice 
after cecal ligation and puncture (CLP). In subsequent experiments, areas of hippocampus 
surrounded by dashed white lines were analyzed. Exposure time of UV laser for 
immunodetection using each marker was normalized by DAPI signal intensities. Scale bar: 
200 μm (lower magnification), 50 μm (higher magnification). Bar represents mean±SEM; (n = 
7: sham, n = 6: cecal ligation and puncture). * P < 0.01 (Student t-test). (from Imamura et. al, 
(2011)) 
4. Cholinergic anti-inflammatory pathway 
Sepsis affects autonomic systems (Tracey KJ, 2002). In lipopolysaccharide-injected rat (i.e., 
an animal model of sepsis), electrical threshold to induce action potentials are increased (i.e., 
hard neuronal firing) in vagus nerve (Huang J et al, 2010). This finding suggests that the 
vagus nerve activity is reduced after sepsis. Conversely, when the vagus nerve is electrically 
charged by external stimulation electrode, sepsis is alleviated (Huston JM et al, 2006; Rosas-
Ballina M et al, 2008; Vida G et al, 2011). The vagus nerve projects parasympathetic neurons 
to all organs except adrenal gland and controls acetylcholinergic synaptic transmission. 
Wang and colleagues ,using 7-subunit of acetylcholine receptor knockout mice, 
demonstrate that vagus nerve stimulation inhibits excess release of tumor necrosis factor 
(i.e., activator of inflammatory mediator) in wild-type mice but not in acetylcholine 
knockout mice (Wang H et al, 2003). In addition, vagus nerve stimulation inhibits organ 
injury in the lung (Boland C et al, 2011), gut (Eisner F et al, 2011), spleen (Vida G et al, 2011) 
after sepsis. Furthermore, excess release of high mobility group box (HMGB)-1  
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Fig. 4. Up-regulation of interleukin (IL)-1 on Iba1-positive cells after cecal ligation and 
puncture (CLP). (A) Staining of IL-1ǃ immunoreactivity (green), Iba1 (marker for microglial 
and/or macrophage phagocytosis) immunoreactivity (red), and DAPI (nuclei, blue) in 
hippocampus from sham-operated mice (left panels) and CLP-treated mice (right panels). 
Magnified view shown in the lower right-hand corner. Merge: white arrow heads in higher 
magnification indicate Iba1 positive cells in the IL-1ǃ positive cells. Scale bar: 200 μm (lower 
magnification), 50 μm (higher magnification). Higher intensity of IL-1ǃ (B) and Iba1 (C) is seen 
in CLP mice. (D) The ordinate shows the percentage of Iba1-positive cells in the IL-1-positive 
cells. The numbers of immunopositive cells were counted between slices, respectively. Almost 
all (>80%) IL-1-positive cells are Iba1-positive after CLP. Bar represents mean±SEM; (n=7: 
sham, n=6: CLP-treated). * P<0.01 (Student t-test). (from Imamura et. al, (2011)) 
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Fig. 5. Increased interleukin (IL)-1 receptor on hippocampal neurons after cecal ligation and 
puncture (CLP). (A) Triple staining of DAPI, type 1 IL-1 receptor (IL-1R1) and NF200. Blue: 
DAPI, green: IL-1R1, red: NF200. Magnified view shown in the lower right-hand corner. 
Merge: white arrow heads in higher magnification indicate NF200 positive cells in the IL-
1R1 positive cells. Scale bar: 200 μm (lower magnification), 50 μm (higher magnification). (B) 
Slight decrease in neuronal fibers after CLP. (C) Increased IL-1R1 intensity after CLP. (D) 
Almost all (>90%) IL-1R1s are distributed on neurons. Bar represents mean±SEM; (n=7: 
sham, n=6: CLP-treated). * P<0.01 (Student t-test). (from Imamura Y et. al, (2011)) 
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Fig. 6. Septic encephalopathy (SE) results in long-term potentiation (LTP) deficiency by 
interleukin (IL)-1ǃ. (A) Successful rates of recording of field excitatory post-synaptic 
potentials (fEPSP) from sham-operated mice and cecal ligation and puncture (CLP)-treated 
mice. Hippocampal perforant-path fibers were stimulated with test pulse stimulation (30-s 
intervals, 200-μs duration, half-maximum intensity). fEPSP was recorded at the dentate 
gyrus at a distance of 300 μm from the stimulation electrode (P<0.002, Student t-test). (B) 
Schematic showing LTP deficiency after CLP. LTP experiments after CLP were performed 
according to the schematic, which shows the time course of the experimental procedure. 
LTP was induced by high-frequency stimulation (100 Hz x 1 s, four times, at 5-min intervals 
indicated by the arrows). Representative traces of baseline at t = 0 min and LTP at t = 80 min 
are shown. Black trace: baseline fEPSP, red trace: fEPSP after LTP. (C) Schematic showing 
cancelation of LTP deficiency in CLP-treated mice by IL-1R antagonist (IL-1ra). Brain slices 
were incubated in the presence of IL-1ra for 30 min before LTP recording. Note that IL-1ra is 
effective for LTP recovery after CLP, and IL-1ra reagent has no effect on fEPSP amplitudes. 
Bar represents mean±SEM; (n = 7: sham, n = 7: CLP-treated). * p < 0.01 (Student t-test). (from 
Imamura et. al, (2011)) 
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(i.e., inflammatory mediator) from macrophage is also inhibited by vagus nerve stimulation 
(Wang H et al, 2004). The neural mechanism of vagus nerve stimulation is summarized in 
review (Tracey KJ, 2009). The review describes the mechanisms as follows: when sepsis is 
induced by endotoxemia, a site of infection imposes cytokine release through NF-kappaB 
(nuclear factor kappa-light-chain enhancer of activated B cells) activation. This signaling 
pathway accelerates cytokine production and thereby cell death via cytokine storm. When 
the vagus nerve from the brain stem is stimulated, it activates cholinergic anti-inflammatory 
pathway (efferent arc) and inhibits innate immune response in the spleen via activation of 
nicotinic acetylcholine receptor. The nicotinic acetylcholine receptor activation suppresses 
NF-kappaB activation via JAK2 (Janus kinase 2, cytokine receptor) - STAT3 (signal 
transducer and activator of transcription 3, transcription activator) pathway and the 
cytokine release. 
Hence, vagus nerve stimulation may employ a high potential for the therapeutics of the 
clinical treatment of sepsis-related systemic inflammatory symptoms of septic 
encephalopathy. 
5. Future prospect: A novel technology for tracking one molecule imaging in 
living organism  
The findings we introduce are mainly resulted from neurochemical research assays using 
dissected tissues and cells. Recently, non-invasive methods such as functional magnetic 
resonance imaging (fMRI) are utilized to examine the brain dysfunction in living organism 
(rodents and human, etc). For example, in a mouse model of sepsis, accumulation of 
effusion by vasogenic edema is observed using fMRI in hippocampus and cortex (Bozza FA 
et al, 2010). Thus, fMRI is a powerful tool to find the damaged region in the brain because of 
the high spatial resolution. However, since fMRI detects the alteration of blood stream and 
estimates this as brain functional alteration, there is a limitation of the fMRI study. For 
example, it is hard to distinguish excitatory or inhibitory neurotransmission without a tag of 
each. In addition, because action potentials propagation between synapses in the brain is 
conducted within 100 msec (Wu JY et al, 2008), it is hard to track the temporal alteration of 
fast synaptic transmission with the time resolution (later than 1s) of fMRI (Tsao J, 2010). To 
reinforce these weak points, we address a novel nano-technology, ‘one molecule imaging 
with quantum dot’ for the future research of septic encephalopathy. 
A quantum dot (q-dot) is a nanometer-sized semiconductor particle (2-10 nm diameter). 
Cadmium selenide (CdSe) and cadmium telluride (CdTe) are well-utilized for the nano-
materials of q-dot. When q-dot is placed in the crystallized structure, its electrical state for 
the fluorescence emission is discretized (Reed MA et al, 1988). As a result, only the 
fluorescence with a specific wavelength is amplified. Immunohistochemical studies using q-
dot have a high signal to noise ratio and few photobleaching(Chan WC, Nie S, 1998). 
Although normal q-dots are hydrophobic, it can be changed their property to hydrophilic in 
order to apply to living organism. Jin T et. al (2008) develop a water-soluble glutathione-
coated Q-dots. They successfully detect q-dot signals in the lymph node in the mouse (Fig. 
7). In addition, q-dot is available to track the molecules expressed in the brain. 
Intraperitoneally-injected q-dots can be found in the brain (Kato S et al, 2010; Yeh TK et al, 
2011). Hence, q-dot is a hopeful nano-material to track a molecule associated with sepsis. 
Then, how do we track the molecules associated with septic encephalopathy with q-dots? 
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Fig. 7. Lymph node imaging by near infra-red q-dot (from Jin T. (2008))  
Near infrared spectroscopy (NIRS) uses near infra-red region (800-2500nm) of light. Since 
the light in near infra -red range can pass through the skull, reach to the surface of the brain 
and coincide with the fast event-related responses in human recorded by 
electroencephalograms (Medvedev AV et al, 2010), it has been used to track cerebral 
hemodynamics (Gratton E et al, 2005) and human brain activity(Perrey S, 2008). On the 
other hand, trials to apply q-dots to the molecules associated with pathological states are 
performed in neurosurgery (Taghva A et al, 2010) and brain tumor (Popescu MA & Toms 
SA, 2006). Therefore, if labeling of brain with q-dot which emits the fluorescence light in the 
near infra-red region becomes successful, we can track the molecules associated with septic 
encephalopathy in higher temporal resolution in the future studies.  
6. Conclusion 
Septic encephalopathy is associated with many kinds of inflammatory cytokines, receptors, 
chemicals such as interleukin family, toll-like receptor, tumor necrosis factor, high mobility 
group box. Since these inflammatory molecules induce systemic inflammatory response in the 
whole body and affect the brain function after blood brain barrier disruption, they occurs 
neurological symptoms such as vasogenic edema, aberrant synaptic transmission and 
plasticity. In addition, the weakness of vagus nerve after septic encephalopathy is related to 
the pathophysiology. Although the molecular mechanisms for sepsis are explained, medical 
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intervention for patients of septic encephalopathy in intensive care unit is largely limited to 
symptomatic treatment. The reason is that spatial and temporal dynamics of the functional 
molecular patterns in various organs for the cause of septic symptoms are still not fully 
described. For the future medical treatment of septic encephalopathy, we address the two 
possibilities. First, to find the spatial and temporal dynamics of molecules, q-dots labeled with 
molecules for septic encephalopathy are recorded with both of near infra-red spectroscopy and 
functional magnetic resonance imaging. Second, to alleviate the symptoms, it may be effective 
to stimulate the vagus nerve with non-invasive method, since vagus nerve stimulation can 
reduce the excess inflammatory cytokine release by mechanisms of nicotinic acetylcholine 
receptor activation, which inhibits apoptotic and necrotic pathway of cells and tissues after 
sepsis. These novel approaches will progress the intervention for the sepsis and its 
encephalopathy in the future studies. 
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